Cargando…

Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells

In this study, a series of coumarin derivatives, either alone or as hybrids with cinnamic acid, were synthesized and evaluated for their cytotoxicity against a panel of cancer cells using the MTT assay. Then, the most active compounds were inspected for their mechanism of cytotoxicity by cell-cycle...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishk, Safaa M., Eltamany, Enas E., Nafie, Mohamed S., Khinkar, Roaa M., Hareeri, Rawan H., Elhady, Sameh S., Yassen, Asmaa S. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571264/
https://www.ncbi.nlm.nih.gov/pubmed/36235247
http://dx.doi.org/10.3390/molecules27196709
_version_ 1784810321436737536
author Kishk, Safaa M.
Eltamany, Enas E.
Nafie, Mohamed S.
Khinkar, Roaa M.
Hareeri, Rawan H.
Elhady, Sameh S.
Yassen, Asmaa S. A.
author_facet Kishk, Safaa M.
Eltamany, Enas E.
Nafie, Mohamed S.
Khinkar, Roaa M.
Hareeri, Rawan H.
Elhady, Sameh S.
Yassen, Asmaa S. A.
author_sort Kishk, Safaa M.
collection PubMed
description In this study, a series of coumarin derivatives, either alone or as hybrids with cinnamic acid, were synthesized and evaluated for their cytotoxicity against a panel of cancer cells using the MTT assay. Then, the most active compounds were inspected for their mechanism of cytotoxicity by cell-cycle analysis, RT-PCR, DNA fragmentation, and Western blotting techniques. Cytotoxic results showed that compound (4) had a significant cytotoxic effect against HL60 cells (IC(50) = 8.09 µM), while compound (8b) had a noticeable activity against HepG2 cells (IC(50) = 13.14 µM). Compounds (4) and (8b) mediated their cytotoxicity via PI3K/AKT pathway inhibition. These results were assured by molecular docking studies. These results support further exploratory research focusing on the therapeutic activity of coumarin derivatives as cytotoxic agents.
format Online
Article
Text
id pubmed-9571264
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95712642022-10-17 Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells Kishk, Safaa M. Eltamany, Enas E. Nafie, Mohamed S. Khinkar, Roaa M. Hareeri, Rawan H. Elhady, Sameh S. Yassen, Asmaa S. A. Molecules Article In this study, a series of coumarin derivatives, either alone or as hybrids with cinnamic acid, were synthesized and evaluated for their cytotoxicity against a panel of cancer cells using the MTT assay. Then, the most active compounds were inspected for their mechanism of cytotoxicity by cell-cycle analysis, RT-PCR, DNA fragmentation, and Western blotting techniques. Cytotoxic results showed that compound (4) had a significant cytotoxic effect against HL60 cells (IC(50) = 8.09 µM), while compound (8b) had a noticeable activity against HepG2 cells (IC(50) = 13.14 µM). Compounds (4) and (8b) mediated their cytotoxicity via PI3K/AKT pathway inhibition. These results were assured by molecular docking studies. These results support further exploratory research focusing on the therapeutic activity of coumarin derivatives as cytotoxic agents. MDPI 2022-10-09 /pmc/articles/PMC9571264/ /pubmed/36235247 http://dx.doi.org/10.3390/molecules27196709 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kishk, Safaa M.
Eltamany, Enas E.
Nafie, Mohamed S.
Khinkar, Roaa M.
Hareeri, Rawan H.
Elhady, Sameh S.
Yassen, Asmaa S. A.
Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells
title Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells
title_full Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells
title_fullStr Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells
title_full_unstemmed Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells
title_short Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells
title_sort design and synthesis of coumarin derivatives as cytotoxic agents through pi3k/akt signaling pathway inhibition in hl60 and hepg2 cancer cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571264/
https://www.ncbi.nlm.nih.gov/pubmed/36235247
http://dx.doi.org/10.3390/molecules27196709
work_keys_str_mv AT kishksafaam designandsynthesisofcoumarinderivativesascytotoxicagentsthroughpi3kaktsignalingpathwayinhibitioninhl60andhepg2cancercells
AT eltamanyenase designandsynthesisofcoumarinderivativesascytotoxicagentsthroughpi3kaktsignalingpathwayinhibitioninhl60andhepg2cancercells
AT nafiemohameds designandsynthesisofcoumarinderivativesascytotoxicagentsthroughpi3kaktsignalingpathwayinhibitioninhl60andhepg2cancercells
AT khinkarroaam designandsynthesisofcoumarinderivativesascytotoxicagentsthroughpi3kaktsignalingpathwayinhibitioninhl60andhepg2cancercells
AT hareerirawanh designandsynthesisofcoumarinderivativesascytotoxicagentsthroughpi3kaktsignalingpathwayinhibitioninhl60andhepg2cancercells
AT elhadysamehs designandsynthesisofcoumarinderivativesascytotoxicagentsthroughpi3kaktsignalingpathwayinhibitioninhl60andhepg2cancercells
AT yassenasmaasa designandsynthesisofcoumarinderivativesascytotoxicagentsthroughpi3kaktsignalingpathwayinhibitioninhl60andhepg2cancercells